Corvus Pharmaceuticals Inc. (CRVS)
NASDAQ: CRVSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 10.52 +1.06%
CRVS stock chart
Technical analysisKey statistics
All statistics- Market cap
- $875.70M
- EPS (TTM)
- -$0.62
- Dividend yield
- None
- 52-week range
- 6.39 – 26.95
- Day range
- 10.25 – 10.65
- Volume / Avg
- 1.16M / 996.12K
- Beta
- —
- Shares outstanding
- 84.12M
- Next earnings
- Nov 3, 2026
52-week range
CRVS stock today
Corvus Pharmaceuticals (CRVS) closed at $10.41 on Oct 7, down 1.42% (-$0.15), versus the S&P 500's 0.22% decline. At this level, CRVS sits near the bottom of its 52-week range of $6.39 to $26.95: 61.4% below the high, set on Jan 23, 2026 and 62.9% above the low. CRVS is up 35.2% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 51.5%.
Corvus Pharmaceuticals has posted a net loss over the last twelve months (EPS of -$0.62), so its P/E ratio is not meaningful. Corvus Pharmaceuticals's next earnings report is expected on Nov 3, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Corvus Pharmaceuticals
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2016
Earnings
Earnings history- Next report
- Nov 3, 2026
- EPS estimate
- $-0.21
Corvus Pharmaceuticals peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| RIGLRigel Pharmaceuticals Inc. | 47.99 | +4.08% | $896.45M | vs CRVS |
| CYRXCryoPort Inc. | 17.35 | -2.53% | $878.76M | vs CRVS |
| ALMSAlumis Inc. | 6.77 | -2.31% | $876.28M | vs CRVS |
| JBIOJade Biosciences Inc. | 13.77 | +2.68% | $875.74M | vs CRVS |
| ANLAdlai Nortye Group Ltd. ADR | 14.05 | -2.84% | $904.79M | vs CRVS |
| MLTXMoonLake Immunotherapeutics Class A | 10.77 | -1.64% | $916.60M | vs CRVS |
| ANROAlto Neuroscience Inc. | 23.52 | -0.72% | $922.97M | vs CRVS |
| ARDXArdelyx Inc. | 3.26 | -1.51% | $841.69M | vs CRVS |
Indexes, lists and sector
Corvus Pharmaceuticals stock FAQ
What is Corvus Pharmaceuticals's stock price today?
CRVS last traded at $10.41 as of Oct 7, 4:00 PM EDT, down 1.42% on the day. Prices are delayed at least 15 minutes.
When is Corvus Pharmaceuticals's next earnings date?
Corvus Pharmaceuticals is expected to report earnings on Tuesday, November 3, 2026. Analysts expect EPS of $-0.21.
What is the CRVS 52-week high?
The 52-week high for CRVS is $26.95 and the 52-week low is $6.39. The stock is currently 61.4% below its high.